57 related articles for article (PubMed ID: 20207653)
1. Insulin resistance, viral load and response to peginterferon and ribavirin in patients with chronic hepatitis C virus infection.
Dai CY; Huang JF; Hsieh MY; Chuang WL; Yu ML
Gut; 2010 Mar; 59(3):418. PubMed ID: 20207653
[No Abstract] [Full Text] [Related]
2. Danoprevir, an HCV NS3/4A protease inhibitor, improves insulin sensitivity in patients with genotype 1 chronic hepatitis C.
Moucari R; Forestier N; Larrey D; Guyader D; Couzigou P; Benhamou Y; Voitot H; Vidaud M; Seiwert S; Bradford B; Zeuzem S; Marcellin P
Gut; 2010 Dec; 59(12):1694-8. PubMed ID: 20861007
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus RNA load in relapsed patients: week two of treatment is the best time to predict the complete response.
Halfon P; Khiri H; Tran A; Pénaranda G; Courcambeck J; Joly H; Ouzan D
Eur J Gastroenterol Hepatol; 2003 Oct; 15(10):1067-71. PubMed ID: 14501613
[TBL] [Abstract][Full Text] [Related]
4. Insulin resistance and response to antiviral therapy in chronic hepatitis C: mechanisms and management.
del Campo JA; López RA; Romero-Gómez M
Dig Dis; 2010; 28(1):285-93. PubMed ID: 20460925
[TBL] [Abstract][Full Text] [Related]
5. Ribavirin concentration is a more important predictor of sustained viral response than anemia in hepatitis C patients.
van Vlerken LG; van Oijen MG; van Erpecum KJ
Gastroenterology; 2011 May; 140(5):1693-4; author reply 1694. PubMed ID: 21440580
[No Abstract] [Full Text] [Related]
6. Review article: predicting response in hepatitis C virus therapy.
Mihm U; Herrmann E; Sarrazin C; Zeuzem S
Aliment Pharmacol Ther; 2006 Apr; 23(8):1043-54. PubMed ID: 16611264
[TBL] [Abstract][Full Text] [Related]
7. Interferon treatment for patients with chronic hepatitis C infected with high viral load of genotype 2 virus.
Nakamura H; Ogawa H; Kuroda T; Yamamoto M; Enomoto H; Kishima Y; Yoshida K; Ito H; Matsuda M; Noguchi S
Hepatogastroenterology; 2002; 49(47):1373-6. PubMed ID: 12239945
[TBL] [Abstract][Full Text] [Related]
8. Insulin resistance and response to therapy in patients infected with chronic hepatitis C virus genotypes 2 and 3.
Poustchi H; Negro F; Hui J; Cua IH; Brandt LR; Kench JG; George J
J Hepatol; 2008 Jan; 48(1):28-34. PubMed ID: 17977612
[TBL] [Abstract][Full Text] [Related]
9. Ribavirin in hepatitis C related cryoglobulinemia.
Durand JM; Cacoub P; Lunel-Fabiani F; Cosserat J; Cretel E; Kaplanski G; Frances C; Bletry O; Soubeyrand J; Godeau P
J Rheumatol; 1998 Jun; 25(6):1115-7. PubMed ID: 9632073
[TBL] [Abstract][Full Text] [Related]
10. Cause-effect relationship between the hepatitis C virus and insulin resistance at the time of direct antiviral therapy.
Negro F
Gut; 2010 Dec; 59(12):1590-1. PubMed ID: 20926646
[No Abstract] [Full Text] [Related]
11. Type 2 diabetes mellitus in chronic hepatitis C virus infection: risk factor or consequence?
Abenavoli L; Rouabhia S
Expert Rev Gastroenterol Hepatol; 2013 May; 7(4):295-7. PubMed ID: 23639086
[No Abstract] [Full Text] [Related]
12. Diagnosis and management of hepatitis C.
Vine LJ; Sieberhagen C; Cramp ME
Br J Hosp Med (Lond); 2015 Nov; 76(11):625-30. PubMed ID: 26551491
[TBL] [Abstract][Full Text] [Related]
13. Ipilimumab-induced hepatitis C viral suppression.
Minter S; Willner I; Shirai K
J Clin Oncol; 2013 Jul; 31(19):e307-8. PubMed ID: 23690418
[No Abstract] [Full Text] [Related]
14. [Management of chronic hepatitis C in 2008].
Pol S; Marcellin P
Gastroenterol Clin Biol; 2008 Mar; 32(3 Pt 2):S121-4. PubMed ID: 18675182
[No Abstract] [Full Text] [Related]
15. Hepatitis C treatment completion rates in routine clinical care.
Ridruejo E
Liver Int; 2010 Aug; 30(7):1082; author reply 1083. PubMed ID: 20214733
[No Abstract] [Full Text] [Related]
16. [Breakthrough in the treatment of chronic hepatitis C virus infections. Direct acting antivirals heals over 90 percent].
Weiland O
Lakartidningen; 2014 Nov; 111(51-52):2280-1. PubMed ID: 25423337
[No Abstract] [Full Text] [Related]
17. Curing chronic hepatitis C--the arc of a medical triumph.
Chung RT; Baumert TF
N Engl J Med; 2014 Apr; 370(17):1576-8. PubMed ID: 24720678
[No Abstract] [Full Text] [Related]
18. Hepatitis C Virus is Treatable but We Need to Be Sure of a Cure.
Malnick S; Maor Y
Isr Med Assoc J; 2021 Dec; 23(12):819-820. PubMed ID: 34954924
[No Abstract] [Full Text] [Related]
19. Chronic hepatitis C infection and insulin resistance: two best friends.
Abenavoli L; Almasio PL
Expert Rev Anti Infect Ther; 2011 Aug; 9(8):555-8. PubMed ID: 21819320
[No Abstract] [Full Text] [Related]
20. Insulin resistance in chronic hepatitis C: the search for effective drug treatment continues.
Harrison SA; Lincoln MJ; Roberts KK
Expert Rev Gastroenterol Hepatol; 2012 Aug; 6(4):401-3. PubMed ID: 22928890
[No Abstract] [Full Text] [Related]
[Next] [New Search]
